MoonLake Immunotherapeutics
MLTX
#3375
Rank
NZ$5.86 B
Marketcap
$93.06
Share price
4.74%
Change (1 day)
23.66%
Change (1 year)

EPS for MoonLake Immunotherapeutics (MLTX)

EPS in 2023 (TTM): -$1.93

According to MoonLake Immunotherapeutics's latest financial reports the company's current EPS (TTM) is -$2.00. In 2022 the company made an earnings per share (EPS) of -$2.53.

EPS history for MoonLake Immunotherapeutics from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.93-23.86%
2022-$2.53